BRUSSELS -(Dow Jones)- Belgium's Solvay SA (SOLB.BT) confirmed Monday it is selling its pharmaceutical activities to U.S. rival Abbott Laboratories (ABT) for about EUR5.2 billion and will be reinvesting the proceeds to expand in its plastics and chemicals businesses. Abbott...